Yuping Xu

1.8k total citations
66 papers, 1.5k citations indexed

About

Yuping Xu is a scholar working on Molecular Biology, Biomedical Engineering and Materials Chemistry. According to data from OpenAlex, Yuping Xu has authored 66 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 13 papers in Biomedical Engineering and 11 papers in Materials Chemistry. Recurrent topics in Yuping Xu's work include Nanoplatforms for cancer theranostics (11 papers), Nanoparticle-Based Drug Delivery (8 papers) and RNA Interference and Gene Delivery (5 papers). Yuping Xu is often cited by papers focused on Nanoplatforms for cancer theranostics (11 papers), Nanoparticle-Based Drug Delivery (8 papers) and RNA Interference and Gene Delivery (5 papers). Yuping Xu collaborates with scholars based in China, Fiji and United States. Yuping Xu's co-authors include Min Yang, Donghui Pan, Junjie Yan, Xinyu Wang, Runlin Yang, Lizhen Wang, Deborah A. Berkich, Kathryn F. LaNoue, Jie Sheng and Susan M. Hutson and has published in prestigious journals such as Advanced Materials, Journal of Neuroscience and ACS Nano.

In The Last Decade

Yuping Xu

62 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuping Xu China 23 512 301 286 227 196 66 1.5k
Qingzhu Liu China 21 295 0.6× 280 0.9× 324 1.1× 124 0.5× 112 0.6× 119 1.5k
Motohiro Takeda Japan 27 350 0.7× 485 1.6× 472 1.7× 172 0.8× 158 0.8× 85 2.0k
Laura Calderan Italy 21 448 0.9× 149 0.5× 282 1.0× 152 0.7× 75 0.4× 56 1.5k
Florence Appaix France 20 798 1.6× 190 0.6× 285 1.0× 147 0.6× 148 0.8× 32 1.5k
P. Louise Coletta United Kingdom 27 582 1.1× 363 1.2× 639 2.2× 196 0.9× 119 0.6× 81 2.2k
Yoshichika Yoshioka Japan 25 733 1.4× 548 1.8× 371 1.3× 195 0.9× 97 0.5× 103 2.5k
Inchan Kwon South Korea 24 1.1k 2.2× 193 0.6× 328 1.1× 225 1.0× 73 0.4× 87 2.0k
Dehua Huang China 17 483 0.9× 290 1.0× 429 1.5× 68 0.3× 133 0.7× 48 1.3k
Lihong Bu China 20 599 1.2× 484 1.6× 741 2.6× 437 1.9× 73 0.4× 63 2.0k

Countries citing papers authored by Yuping Xu

Since Specialization
Citations

This map shows the geographic impact of Yuping Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuping Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuping Xu more than expected).

Fields of papers citing papers by Yuping Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuping Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuping Xu. The network helps show where Yuping Xu may publish in the future.

Co-authorship network of co-authors of Yuping Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Yuping Xu. A scholar is included among the top collaborators of Yuping Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuping Xu. Yuping Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pan, Donghui, Junjie Yan, Lizhen Wang, et al.. (2025). Development of Novel Peptide-Based Radiotracers for Detecting FGL1 Expression in Tumors. Molecular Pharmaceutics. 22(3). 1605–1614.
2.
Chen, Chongyang, Yujie Zhao, Xinyu Wang, et al.. (2025). Mitochondrial Dysfunction in Neurodegenerative Diseases. MedComm. 6(9).
3.
Chen, Su, Jianhan Lin, Cong Li, et al.. (2025). Tumor-specific liquid metal nitric oxide nanogenerator for enhanced breast cancer therapy. Asian Journal of Pharmaceutical Sciences. 20(2). 101018–101018. 1 indexed citations
4.
Xu, Wei, Junjie Yan, Xinyu Wang, et al.. (2025). Development and evaluation of a 99mTc-labeled olaparib analog for PARP imaging. EJNMMI Radiopharmacy and Chemistry. 10(1). 46–46. 1 indexed citations
5.
Yan, Junjie, Su Chen, Xinyu Wang, et al.. (2025). A Novel Arene Trifluoromethyl-Based 18F-Labeling Strategy for Enhanced Biomolecular Tracer Development in PET Imaging. Molecular Pharmaceutics. 22(10). 5860–5869.
6.
Xu, Yuping, Bo Chen, Solomon Felix Dan, et al.. (2023). Comparative assessment of the environmental pollution and marine economic growth of Guangxi and China by using the environmental Kuznets curve fitting model. Environmental Science and Pollution Research. 30(56). 119406–119418. 1 indexed citations
7.
Chen, Qingsong, Di Wang, Xin Li, et al.. (2023). In situ structural evolution of BiOCOOH nanowires and their performance towards electrocatalytic CO2 reduction. Nano Research. 16(5). 6661–6669. 30 indexed citations
8.
Pan, Donghui, Yuping Xu, Xinyu Wang, et al.. (2023). Evaluation the in vivo behaviors of PM2.5 in rats using noninvasive PET imaging with mimic particles. Chemosphere. 339. 139663–139663. 1 indexed citations
9.
Fang, Xiaotian T., Takuya Toyonaga, Yuping Xu, et al.. (2020). Quantification of SV2A Binding in Rodent Brain Using [18F]SynVesT-1 and PET Imaging. Molecular Imaging and Biology. 23(3). 372–381. 22 indexed citations
10.
Zhou, Nina, Chang Liu, Xiaoyi Guo, et al.. (2020). Impact of 68Ga-NOTA-MAL-MZHER2 PET imaging in advanced gastric cancer patients and therapeutic response monitoring. European Journal of Nuclear Medicine and Molecular Imaging. 48(1). 161–175. 31 indexed citations
11.
Li, Haiyan, et al.. (2020). MicroRNA‑193b regulates human ovarian cancer cell growth via targeting STMN1. Experimental and Therapeutic Medicine. 20(4). 3310–3315. 12 indexed citations
12.
Xu, Yuping, Lizhen Wang, Donghui Pan, et al.. (2020). Synthesis of a novel 89Zr-labeled HER2 affibody and its application study in tumor PET imaging. EJNMMI Research. 10(1). 58–58. 16 indexed citations
13.
Wang, Xinyu, Junjie Yan, Lizhen Wang, et al.. (2020). Oral delivery of anti-TNF antibody shielded by natural polyphenol-mediated supramolecular assembly for inflammatory bowel disease therapy. Theranostics. 10(23). 10808–10822. 76 indexed citations
14.
Wang, Xinyu, Junjie Yan, Donghui Pan, et al.. (2018). Polyphenol–Poloxamer Self‐Assembled Supramolecular Nanoparticles for Tumor NIRF/PET Imaging. Advanced Healthcare Materials. 7(15). e1701505–e1701505. 73 indexed citations
15.
Pan, Yu, Jing Lv, Donghui Pan, et al.. (2018). Evaluating the utility of human glucagon-like peptide 1 receptor gene as a novel radionuclide reporter gene: a promising molecular imaging tool. Applied Microbiology and Biotechnology. 103(3). 1311–1324. 2 indexed citations
16.
Xu, Yuping, et al.. (2016). On Temperature Field Distribution and the Effects of Surrounding Rock Properties on Tunnels in Cold Regions. 53(6). 72. 2 indexed citations
17.
Yang, Runlin, Ping Liu, Donghui Pan, et al.. (2016). An Investigation on a Novel Anti-tumor Fusion Peptide of FSH33-53-IIKK. Journal of Cancer. 7(8). 1010–1019. 2 indexed citations
18.
Li, Haiyan, et al.. (2015). Tissue miR-193b as a Novel Biomarker for Patients with Ovarian Cancer. Medical Science Monitor. 21. 3929–3934. 33 indexed citations
19.
Ola, Mohammad Shamsul, Deborah A. Berkich, Yuping Xu, et al.. (2005). Analysis of glucose metabolism in diabetic rat retinas. American Journal of Physiology-Endocrinology and Metabolism. 290(6). E1057–E1067. 75 indexed citations
20.
Berkich, Deborah A., Yuping Xu, Kathryn F. LaNoue, Rolf Gruetter, & Susan M. Hutson. (2004). Evaluation of brain mitochondrial glutamate and α‐ketoglutarate transport under physiologic conditions. Journal of Neuroscience Research. 79(1-2). 106–113. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026